Nicolette Charles A.

Avg. Two Year Performance

(97%) Avg. Purchase Return
(40%) Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(4%)(38%)(25%)(34%)(97%)
Purchase Success Rate0 of 10 of 10 of 10 of 10 of 1
Average Sale Return49%78%45%0%0%
Sale Success Rate1 of 11 of 11 of 10 of 10 of 1

Argos Therapeutics Inc

Other » Other

CSO and Vice President of R&D:

Holdings: 20.06K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--